Clinical Trials
Treatment of retinal diseases is a rapidly changing field of medicine with new techniques and procedures being developed every year. Southwest Retina Specialists has been involved with research over the last six years for a variety of retina conditions, including Diabetic Macular Edema, Vitreous Hemorrhage with surgical intervention, and Age-Related Macular Degeneration.
While clinical trials are always voluntary, to qualify, patients need to go through a screening process prior to enrollment. Each studies eligibility and criteria vary.
Please contact one of our study coordinators, Kasey Dalrymple or Rachel Barbee at 806-351-1870 (ext. 1113 or ext. 1148) if you are interested in being screened or want more information on a clinical trial being conducted.
You can learn more about each trial and how to participate in a clinical trial at:
http://www.ClinicalTrials.gov
http://www.fda.gov
Current Studies, Open for Enrollment
To be determined, current as of 09/Sep/2022
Ongoing Studies (Closed Enrollment)
GLOW
Moderate Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR) (Ongoing, Actively Recruiting)
Kodiak Sciences
This is a Phase 3, prospective, randomized, double-masked, sham-controlled, two-arm, multicenter study evaluating the efficacy and safety of repeated intravitreal dosing of KSI-301 5 mg in participants with moderately severe to severe non-proliferative diabetic retinopathy (NPDR).
- ClinicalTrials.gov Identifier: NCT05066230
- Sponsor: Kodiak Sciences Inc
- Site: Southwest Retina Specialist, Amarillo, TX.
DAYLIGHT
Neovascular (Wet) Age Related Macular Degeneration (Ongoing, Closed Enrollment)
Kodiak Sciences
This is a Phase 3, prospective, randomized, double-masked, two-arm, multi-center non-inferiority study evaluating the efficacy and safety of repeated intravitreal dosing of KSI-301 5 mg in participants with visual impairment due to treatment-naïve neovascular (wet) age-related macular degeneration (wAMD)
- ClinicalTrials.gov Identifier: NCT04964089
- Sponsor: Kodiak Sciences Inc
- Site: Southwest Retina Specialist, Amarillo, TX.
GATHER2
Geographic Atrophy Secondary to Age-Related Macular Degeneration (Ongoing, Not Recruiting)
IVERIC BIO (ISEE2008)
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- ClinicalTrials.gov Identifier: NCT04435366
- Sponsor: IVERIC BIO (ISEE2008)
- Site: Southwest Retina Specialist, Amarillo, TX.
GLEAM
Treatment-Naïve DME.(Ongoing, Closed Enrollment)
Kodiak Sciences
This is a Phase 3, prospective, randomized, double-masked, two-arm, multi-center non-inferiority study evaluating the efficacy and safety of repeated intravitreal dosing of KSI-301 5 mg in participants with treatment-naïve DME.
- ClinicalTrials.gov Identifier: NCT04611152
- Sponsor: Kodiak Sciences Inc
- Site: Southwest Retina Specialist, Amarillo, TX.